Literature DB >> 27714633

Hypoxic and Reoxygenated Microenvironment: Stemness and Differentiation State in Glioblastoma.

Mariana Maier Gaelzer1,2, Mariana Silva Dos Santos3, Bárbara Paranhos Coelho3, Alice Hoffman de Quadros3, Fabrício Simão4, Vanina Usach5, Fátima Costa Rodrigues Guma3, Patrícia Setton-Avruj5, Guido Lenz6, Christianne G Salbego3.   

Abstract

Glioblastoma (GBM) is the most common and aggressive primary malignant brain tumor in adults. Hypoxia is a distinct feature in GBM and plays a significant role in tumor progression, resistance to treatment, and poor outcome. However, there is lack of studies relating type of cell death, status of Akt phosphorylation on Ser473, mitochondrial membrane potential, and morphological changes of tumor cells after hypoxia and reoxygenation. The rat glioma C6 cell line was exposed to oxygen deprivation (OD) in 5 % fetal bovine serum (FBS) or serum-free media followed by reoxygenation (RO). OD induced apoptosis on both 5 % FBS and serum-free groups. Overall, cells on serum-free media showed more profound morphological changes than cells on 5 % FBS. Moreover, our results suggest that OD combined with absence of serum provided a favorable environment for glioblastoma dedifferentiation to cancer stem cells, since nestin, and CD133 levels increased. Reoxygenation is present in hypoxic tumors through microvessel formation and cell migration to oxygenated areas. However, few studies approach these phenomena when analyzing hypoxia. We show that RO caused morphological alterations characteristic of cells undergoing a differentiation process due to increased GFAP. In the present study, we characterized an in vitro hypoxic microenvironment associated with GBM tumors, therefore contributing with new insights for the development of therapeutics for resistant glioblastoma.

Entities:  

Keywords:  C6; Cancer; Cancer stem cell; Glioma; Hypoxia; Reoxygenation

Mesh:

Substances:

Year:  2016        PMID: 27714633     DOI: 10.1007/s12035-016-0126-6

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  38 in total

1.  Cancer stem cells. VEGF promotes stemness.

Authors:  Sarah Seton-Rogers
Journal:  Nat Rev Cancer       Date:  2011-11-17       Impact factor: 60.716

2.  Single-cell mRNA profiling identifies progenitor subclasses in neurospheres.

Authors:  Gunaseelan Narayanan; Anuradha Poonepalli; Jinmiao Chen; Shvetha Sankaran; Srivats Hariharan; Yuan Hong Yu; Paul Robson; Henry Yang; Sohail Ahmed
Journal:  Stem Cells Dev       Date:  2012-09-10       Impact factor: 3.272

3.  Purification of a pluripotent neural stem cell from the adult mouse brain.

Authors:  R L Rietze; H Valcanis; G F Brooker; T Thomas; A K Voss; P F Bartlett
Journal:  Nature       Date:  2001-08-16       Impact factor: 49.962

4.  Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion.

Authors:  David Zagzag; Yevgeniy Lukyanov; Li Lan; M Aktar Ali; Mine Esencay; Olga Mendez; Herman Yee; Evelyn B Voura; Elizabeth W Newcomb
Journal:  Lab Invest       Date:  2006-10-30       Impact factor: 5.662

5.  Cyclic AMP decreases the expression of a neuronal marker (GAD67) and increases the expression of an astroglial marker (GFAP) in C6 cells.

Authors:  J Segovia; G M Lawless; N J Tillakaratne; M Brenner; A J Tobin
Journal:  J Neurochem       Date:  1994-10       Impact factor: 5.372

6.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

7.  Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay.

Authors:  Petra Knizetova; Jiri Ehrmann; Alice Hlobilkova; Iveta Vancova; Ondrej Kalita; Zdenek Kolar; Jiri Bartek
Journal:  Cell Cycle       Date:  2008-08-12       Impact factor: 4.534

Review 8.  Cancer stem cells and cell size: A causal link?

Authors:  Qiuhui Li; Kiera Rycaj; Xin Chen; Dean G Tang
Journal:  Semin Cancer Biol       Date:  2015-08-01       Impact factor: 15.707

9.  Mesenchymal stem cell-derived CCL-9 and CCL-5 promote mammary tumor cell invasion and the activation of matrix metalloproteinases.

Authors:  Muthulekha Swamydas; Krista Ricci; Stephen L Rego; Didier Dréau
Journal:  Cell Adh Migr       Date:  2013-05-24       Impact factor: 3.405

10.  Molecular ordering of hypoxia-induced apoptosis: critical involvement of the mitochondrial death pathway in a FADD/caspase-8 independent manner.

Authors:  Martin Weinmann; Verena Jendrossek; Rene Handrick; Dilek Güner; Barbara Goecke; Claus Belka
Journal:  Oncogene       Date:  2004-05-06       Impact factor: 9.867

View more
  6 in total

1.  Suppression of Inner Mitochondrial Membrane Peptidase 2-Like (IMMP2L) Gene Exacerbates Hypoxia-Induced Neural Death Under High Glucose Condition.

Authors:  Yi Ma; Zijing Zhang; Zhirong Chen; Nina Ma; Shihui Sun; Jingwen Zhang; Xinli Ni; Jianzhong Zhang; P Andy Li
Journal:  Neurochem Res       Date:  2017-03-18       Impact factor: 3.996

Review 2.  Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.

Authors:  Masoud Najafi; Bagher Farhood; Keywan Mortezaee; Ebrahim Kharazinejad; Jamal Majidpoor; Reza Ahadi
Journal:  J Cancer Res Clin Oncol       Date:  2019-11-16       Impact factor: 4.553

3.  Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.

Authors:  Valentina Lulli; Mariachiara Buccarelli; Ramona Ilari; Giorgia Castellani; Chiara De Dominicis; Alessandra Di Giamberardino; Quintino Giorgio D Alessandris; Stefano Giannetti; Maurizio Martini; Vittorio Stumpo; Alessandra Boe; Gabriele De Luca; Mauro Biffoni; Giovanna Marziali; Roberto Pallini; Lucia Ricci-Vitiani
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

4.  ADP-Ribosylation Factor Like GTPase 4C (ARL4C) augments stem-like traits of glioblastoma cells by upregulating ALDH1A3.

Authors:  Qian Chen; Wen-Juan Fu; Xiao-Peng Tang; Lu Wang; Qin Niu; Shuai Wang; Yong Lin; Mian-Fu Cao; Rong Hu; Hai-Yan Wen; Yan Wang; Xia Zhang; Xiao-Hong Yao
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

5.  The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines.

Authors:  Lucy Wanjiku Macharia; Wanjiru Muriithi; Carlos Pilotto Heming; Dennis Kirii Nyaga; Veronica Aran; Marianne Wanjiru Mureithi; Valeria Pereira Ferrer; Attilio Pane; Paulo Niemeyer Filho; Vivaldo Moura-Neto
Journal:  BMC Cancer       Date:  2021-11-19       Impact factor: 4.430

6.  A CD10-OGP Membrane Peptolytic Signaling Axis in Fibroblasts Regulates Lipid Metabolism of Cancer Stem Cells via SCD1.

Authors:  Shubin Yu; Yiwen Lu; An Su; Jianing Chen; Jiang Li; Boxuan Zhou; Xinwei Liu; Qidong Xia; Yihong Li; Jiaqian Li; Min Huang; Yingying Ye; Qiyi Zhao; Sushi Jiang; Xiaoqing Yan; Xiaojuan Wang; Can Di; Jiayao Pan; Shicheng Su
Journal:  Adv Sci (Weinh)       Date:  2021-08-07       Impact factor: 16.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.